Narrow search
Showing 51 - 60 of 366,894
Cover Image
Globalización, salud y medicamentos
Molina Salazar, Raúl E.; Rivas Vilchis, José Federico; … - In: Análisis económico 17 (2002) 1, pp. 185-202
Persistent link: https://www.econbiz.de/10001740977
Cover Image
Pharmaceutical Patents and Expropriation in Indian Bilateral Investment Treaties
Ranjan, Prabhash - 2017
This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India's regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory measures such as compulsory licensing of pharmaceutical...
Persistent link: https://www.econbiz.de/10012959457
Cover Image
Designing pro-health competition policies in developing countries
Ido, Vitor Henrique Pinto - 2020
Persistent link: https://www.econbiz.de/10012433548
Cover Image
Market Competition in Aid of Humanitarian Concern : Reconsidering Pharmaceutical Drug Patents
Ilg, Michael P. - 2014
The grant of monopoly patent protection is justified normally as a means for giving incentive for innovation. Market driven innovation is not necessarily equitable, however, and the development concerns over the international intellectual property regime governing the products of medical...
Persistent link: https://www.econbiz.de/10013071057
Cover Image
TRIPS Flexibilities on Patent Enforcement : Lessons from Some Developed Countries Relating to Pharmaceutical Patent Protection
Sarnoff, Joshua D. - 2021
Authority for national judiciaries to issue permanent and preliminary injunctions is required by the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), Articles 44 and 50. But the TRIPS Agreement does not require the issuance of injunctions in any particular...
Persistent link: https://www.econbiz.de/10013212673
Cover Image
Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research
Müller-Langer, Frank - 2009
This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...
Persistent link: https://www.econbiz.de/10013521260
Cover Image
World Bank Pharmaceuticals
Govindaraj, Ramesh; Reich, Michael R.; Cohen, Jillian C. - 2013
, unsafe or improperly used. This World Bank Pharmaceuticals Discussion Paper provides a pragmatic analysis of some of the … Pharmaceuticals Discussion Paper complement and reinforce the objectives outlined in the WHO Medicines Strategy: 2000-2003 (World …Pharmaceuticals have a major impact on health, on government and household spending, and on health systems. Despite the …
Persistent link: https://www.econbiz.de/10012558439
Cover Image
Making markets for vaccines : ideas to action ; the report of the Center for Global Development, Advance Market Commitment Working Group. Ruth Levine, Michael Kremer, Alice Albrigh...
Levine, Ruth E.; Kremer, Michael; Albright, Alice; … - 2005
We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- $3 billion per disease -- Meeting industry requirements -- How sponsors can do it
Persistent link: https://www.econbiz.de/10002764203
Cover Image
Global health economics : shaping health policy in low- and middle-income countries
Revill, Paul (ed.); Suhrcke, Marc (ed.);  … - 2020
"Provides up-to-date research on the theories and applications of health economics. Presents approaches to health economics developed at the University of York which are recognized for their high quality and distinction. Possesses practical tools and methods in dealing with health care...
Persistent link: https://www.econbiz.de/10012025939